Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Non-cash Items: 2023-2024

Historic Non-cash Items for Monte Rosa Therapeutics (GLUE) over the last 2 years, with Dec 2024 value amounting to $6.3 million.

  • Monte Rosa Therapeutics' Non-cash Items rose 282.39% to $15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 282.39%. This contributed to the annual value of $6.3 million for FY2024, which is 61.69% up from last year.
  • Monte Rosa Therapeutics' Non-cash Items amounted to $6.3 million in FY2024, which was up 61.69% from $3.9 million recorded in FY2023.
  • Monte Rosa Therapeutics' 5-year Non-cash Items high stood at $6.3 million for FY2024, and its period low was $3.9 million during FY2023.
  • Over the past 2 years, Monte Rosa Therapeutics' median Non-cash Items value was $5.1 million (recorded in 2023), while the average stood at $5.1 million.
  • Data for Monte Rosa Therapeutics' Non-cash Items shows a peak YoY surged of 61.69% (in 2024) over the last 5 years.
  • Monte Rosa Therapeutics' Non-cash Items (Yearly) stood at $3.9 million in 2023, then soared by 61.69% to $6.3 million in 2024.